Is there a generic for Deserpidine; methyclothiazide?

Yes. The FDA Orange Book lists 2 approved generic (ANDA) applications for Deserpidine; methyclothiazide, referencing the brand ENDURONYL. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Deserpidine; methyclothiazide?

ENDURONYL (NDA 012775, ABBOTT) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Deserpidine; methyclothiazide are approved?

Deserpidine; methyclothiazide is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Deserpidine; methyclothiazide

Deserpidine; methyclothiazide is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ENDURONYL · NDA 012775

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
ENDURONYL×2	ABBOTT	NDA 012775	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (2)

Product	Applicant	Application	TE	Approved
METHYCLOTHIAZIDE AND DESERPIDINE	WATSON LABS	ANDA 088486	—	Aug 10, 1984
METHYCLOTHIAZIDE AND DESERPIDINE	WATSON LABS	ANDA 088452	—	Aug 10, 1984

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Deserpidine; methyclothiazide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo